Related Experiment Video
Updated: Aug 5, 2026
04:34
Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
Published on: June 15, 2011
Cancer and thrombosis revisited
1Department of Hematology, Rambam Medical Center and Bruce Rappaport Faculty of Medicine, Haifa, Israel.
Blood Reviews
|June 21, 2001
Summary
Cancer and thrombosis have a complex, bidirectional relationship. Research is exploring how antithrombotic treatments may improve survival in cancer patients, with ongoing studies on novel anticoagulant drugs.
Area of Science:
- Oncology
- Hematology
- Thrombosis Research
Background:
- The link between cancer and thrombosis (blood clots) has been recognized for over a century.
- Cancer influences the body's clotting system, and blood clots can potentially accelerate tumor growth.
- Cancer patients frequently experience various thrombotic events, affecting both local and systemic circulation.
Purpose of the Study:
- To review the established connection between cancer and coagulation.
- To summarize the clinical manifestations of thrombosis in cancer patients.
- To discuss the emerging evidence on the role of antithrombotic therapies in improving cancer patient outcomes.
Main Methods:
- Literature review and synthesis of existing research on cancer-associated thrombosis.
- Analysis of clinical data regarding thrombotic syndromes in oncology.
- Evaluation of studies investigating the impact of antithrombotic agents on cancer patient survival.
Main Results:
- A clear bidirectional relationship exists between cancer and hemostasis.
- Thrombotic events are common complications in cancer patients.
- Antithrombotic regimens show potential for prolonging survival, though further research is needed.
Conclusions:
- The interplay between cancer and coagulation is significant and multifaceted.
- Antithrombotic strategies are increasingly recognized as important in cancer care.
- Further investigation into novel antithrombotic drugs is warranted to optimize patient outcomes.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...